Adipocyte-fatty acid binding protein induces apoptosis in DU145 prostate cancer cells

Journal of Experimental Therapeutics and Oncology

Volumn 4, Issue 2, 2004, Pages 91-100

  De Santis, Marta L ^a   Hammamieh, Rasha ^a   Das, Rina ^a   Jett, Marti ^a,b  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^b WRAIR   (United States)

Author keywords

Adipocyte Fatty Acid Binding Protein; Apoptosis; Prostate cancer; TNF ; Tumor suppressor

Indexed keywords

ADIPOCYTE FATTY ACID BINDING PROTEIN; CYTOPLASM PROTEIN; DNA FRAGMENT; ECDYSONE; EPIDERMAL GROWTH FACTOR RECEPTOR; FATTY ACID; FATTY ACID BINDING PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PONASTERONE A; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; AUTOCRINE EFFECT; CANCER INHIBITION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CANCER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

APOPTOSIS; CARRIER PROTEINS; CELL LINE, TUMOR; ECDYSTERONE; FATTY ACID-BINDING PROTEINS; GENE EXPRESSION REGULATION; HUMANS; MALE; PROSTATIC NEOPLASMS; SIGNAL TRANSDUCTION; STEROIDS; TRANSFECTION; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 4043073454     PISSN: 13594117     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Reese-Wagoner, A., J. Thompson, and L. Banaszak, Structural properties of the adipocyte lipid binding protein. Biochimica et Biophysica Acta, 1999. 1441(2-3): p. 106-16.
2. Gericke, A., et al., Adipocyte fatty acid-binding protein: interaction with phospholipid membranes and thermal stability studied by FTIR spectroscopy. Biochemistry, 1997. 36(27): p. 8311-7.
3. Buelt, M.K., et al., In vitro phosphorylation of the adipocyte lipid-binding protein (p15) by the insulin receptor. Effects of fatty acid on receptor kinase and substrate phosphorylation. Journal of Biological Chemistry, 1991. 266(19): p. 12266-71.
4. Veerkamp, J.H., R.A. Peelers, and R.G. Maatman, Structural and functional features of different types of cytoplasmic fatty acid-binding proteins. Biochimica et Biophysica Acta, 1991. 1081(1): p. 1-24.
5. Celis, J.E., et al., Loss of adipocyte-type fatty acid binding protein and other protein biomarkers is associated with progression of human bladder transitional cell carcinomas. Cancer Research, 1996. 56(20): p. 4782-90.
6. Das, R., et al., Expression pattern of fatty acid-binding proteins in human normal and cancer prostate cells and tissues. Clinical Cancer Research, 2001. 7(6): p. 1706-15.
7. Huynh, H.T., et al., Tumor suppressor activity of the gene encoding mammary-derived growth inhibitor. Cancer Research, 1995. 55(11): p. 2225-31.
8. Yang, Y., et al., Members of the fatty acid binding protein family are differentiation factors for the mammary gland. Journal of Cell Biology, 1994. 127(4): p. 1097-1109.
9. Russell, P.J., S. Bennett, and P. Stricker, Growth factor involvement in progression of prostate cancer. Clinical Chemistry, 1998. 44(4): p. 705-23.
10. Rhim, H.C., et al., A new technique of administration of oral contrast material for abdominal CT: the drip ingestion method. AJR. American Journal of Roentgenology, 1997. 169(2): p. 495-7.
11. Carpenter, C.L. and L.C. Cantley, Phosphoinositide 3-kinase and the regulation of cell growth. Biochimica et Biophysica Acta, 1996. 1288(1): p. M11-6.
12. Seth, D., et al., Complex post-transcriptional regulation of EGF-receptor expression by EGF and TGF-alpha in human prostate cancer cells. British Journal of Cancer, 1999. 80(5-6): p. 657-69.
13. Sumitomo, M., et al., An essential role for nuclear factor kappa B in preventing TNF-alpha-induced cell death in prostate cancer cells. Journal of Urology, 1999. 161(2): p. 674-9.
14. Snowdon, D.A., R.L. Phillips, and W. Choi, Diet, obesity, and risk of fatal prostate cancer. American Journal of Epidemiology, 1984. 120(2): p. 244-50.
15. Franceschi, S., Fat and prostate cancer.[comment]. Epidemiology, 1994. 5(3): p. 271-3.
16. Wynder, E.L., et al., Metabolic epidemiology of prostatic cancer. Prostate, 1984. 5(1): p. 47-53.
17. Steiner, M.S., et al., Growth inhibition of prostate cancer by an adenovirus expressing a novel tumor suppressor gene, pHyde. Cancer Research, 2000. 60(16): p. 4419-25.
18. Ko, S.C., et al., Molecular therapy with recombinant p53 adenovirus in an androgen-independent, metastatic human prostate cancer model. Human Gene Therapy, 1996. 7(14): p. 1683-91.
19. Gupta, S., et al., Chemoprevention of prostate carcinogenesis by alpha-difluoromethylornithine in TRAMP mice. Cancer Research, 2000. 60(18): p. 5125-33.
20. Harper, M.E., et al., An immunocytochemical analysis of TGF alpha expression in benign and malignant prostatic tumors. Prostate, 1993. 23(1): p. 9-23.
21. Glynne-Jones, E., L. Goddard, and M.E. Harper, Comparative analysis of mRNA and protein expression for epidermal growth factor receptor and ligands relative to the proliferative index in human prostate tissue. Human Pathology, 1996. 27(7): p. 688-94.
22. Cohen, D.W., et al., Expression of transforming growth factor-alpha and the epidermal growth factor receptor in human prostate tissues. Journal of Urology, 1994. 152(6 Pt 1): p. 2120-4.
23. Sherwood, E.R., et al., Epidermal growth factor receptor activation in androgen-independent but not androgen-stimulated growth of human prostatic carcinoma cells. British Journal of Cancer, 1998. 77(6): p. 855-61.
24. Downward, J., Signal transduction. New exchange, new target.[comment]. Nature, 1998. 396(6710): p. 416-7.
25. Franke, T.F., D.R. Kaplan, and L.C. Cantley, PI3K: downstream AKTion blocks apoptosis. Cell, 1997. 88(4): p. 435-7.
26. Hotamisligil, G.S., et al., Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein. Science, 1996. 274(5291): p. 1377-9.
27. Kimura, K. and E.P. Gelmann, Tumor necrosis factor-alpha and Fas activate complementary Fas-associated death domain-dependent pathways that enhance apoptosis induced by gamma-irradiation. Journal of Biological Chemistry, 2000. 275(12): p. 8610-7.
28. Zhou, B.P., et al., HEK-2/neu blocks tumor necrosis factor-induced apoptosis via the Akt/NF-kappaB pathway. Journal of Biological Chemistry, 2000. 275(11): p. 8027-31.
29. Huynh, H., L. Alpert, and M. Pollak, Pregnancy-dependent growth of mammary tumors is associated with overexpression of insulin-like growth factor II. Cancer Research, 1996. 56(16): p. 3651-4.
30. Kreutz, M., et al., Regulation of cellular retinoic acid binding protein (CRABP II) during human monocyte differentiation in vitro. Biochemical & Biophysical Research Communications, 1998. 248(3): p. 830-4.
31. Prinsen, C.F. and J.H. Veerkamp, Transfection of 16 myoblasts with adipocyte fatty acid-binding protein cDNA does not affect fatty acid uptake but disturbs lipid metabolism and fusion. Biochemical Journal, 1998. 329(Pt 2): p. 265-73.